Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience
0
📊
Sign in to get full access
Overview
- Machine learning (ML) has great potential for revolutionizing healthcare, but it faces a reproducibility crisis, especially in medicine.
- ML models may not generalize well when applied to data from different patient populations or acquisition settings.
- This paper addresses this problem in the context of neuroimaging for Alzheimer's disease (AD), schizophrenia (SZ), and brain aging.
Plain English Explanation
The paper describes a new approach to developing machine learning models that can be applied to different groups of people, even if the training data comes from a different group. This is an important problem, as machine learning models for healthcare may not work as well when used on patients that are different from the ones the model was trained on.
The researchers used a technique called "weighted empirical risk minimization" to combine data from different groups of people (e.g., different ages, sexes, races) to build models that can accurately diagnose Alzheimer's disease and schizophrenia, and estimate brain age, even when tested on groups that were different from the training data. This allows the models to be more robust and generalizable.
Technical Explanation
The researchers developed a weighted empirical risk minimization approach that optimally combines data from a "source group" (e.g., subjects stratified by attributes like sex, age, race, clinical cohort) to make predictions on a "target group" (e.g., other sex, age group, etc.) using only a small fraction (10%) of data from the target group.
They applied this method to a large dataset of 15,363 individuals from 20 neuroimaging studies to build ML models for diagnosing AD and SZ, and estimating brain age. The approach achieved very high accuracy, with area under the curve greater than 0.95 for AD classification, greater than 0.7 for SZ classification, and mean absolute error less than 5 years for brain age prediction, across all target groups. This was better than existing domain adaptation techniques and in some cases better than training on all data from the target group.
The researchers also demonstrated the utility of the models for predicting disease progression in individuals with mild cognitive impairment. Additionally, the brain age prediction models provided new clinical insights into correlations with neurophysiological tests.
Critical Analysis
The paper presents a promising approach to address the reproducibility crisis in machine learning for healthcare applications. By leveraging data from diverse sources, the researchers were able to develop models that are more robust and generalizable, which is a critical requirement for real-world deployment.
However, the paper does not provide detailed information on the specifics of the "weighted empirical risk minimization" approach, which makes it difficult to fully assess the technical merits of the method. Additionally, the paper does not discuss potential limitations or caveats, such as the availability and quality of the diverse datasets required for this approach, or potential biases that may be introduced by the data sources.
Further research and validation on larger and more diverse datasets would be needed to fully understand the capabilities and limitations of this approach. Nonetheless, the results presented in the paper suggest that this is a promising direction for improving the reliability and clinical utility of machine learning in healthcare.
Conclusion
This paper introduces a novel machine learning approach that can effectively combine data from multiple sources to build models that are more robust and generalizable. The researchers demonstrated the effectiveness of this approach in the context of neuroimaging for Alzheimer's disease, schizophrenia, and brain aging, achieving state-of-the-art performance and generating new clinical insights.
While further research is needed to fully understand the capabilities and limitations of this method, the results suggest that it has the potential to significantly improve the reproducibility and clinical applicability of machine learning in healthcare, which is a critical step towards realizing the transformative potential of this technology.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
📊
0
Adapting Machine Learning Diagnostic Models to New Populations Using a Small Amount of Data: Results from Clinical Neuroscience
Rongguang Wang, Guray Erus, Pratik Chaudhari, Christos Davatzikos
Machine learning (ML) has shown great promise for revolutionizing a number of areas, including healthcare. However, it is also facing a reproducibility crisis, especially in medicine. ML models that are carefully constructed from and evaluated on a training set might not generalize well on data from different patient populations or acquisition instrument settings and protocols. We tackle this problem in the context of neuroimaging of Alzheimer's disease (AD), schizophrenia (SZ) and brain aging. We develop a weighted empirical risk minimization approach that optimally combines data from a source group, e.g., subjects are stratified by attributes such as sex, age group, race and clinical cohort to make predictions on a target group, e.g., other sex, age group, etc. using a small fraction (10%) of data from the target group. We apply this method to multi-source data of 15,363 individuals from 20 neuroimaging studies to build ML models for diagnosis of AD and SZ, and estimation of brain age. We found that this approach achieves substantially better accuracy than existing domain adaptation techniques: it obtains area under curve greater than 0.95 for AD classification, area under curve greater than 0.7 for SZ classification and mean absolute error less than 5 years for brain age prediction on all target groups, achieving robustness to variations of scanners, protocols, and demographic or clinical characteristics. In some cases, it is even better than training on all data from the target group, because it leverages the diversity and size of a larger training set. We also demonstrate the utility of our models for prognostic tasks such as predicting disease progression in individuals with mild cognitive impairment. Critically, our brain age prediction models lead to new clinical insights regarding correlations with neurophysiological tests.
Read more9/16/2024
🌿
0
A Machine Learning Approach for Identifying Anatomical Biomarkers of Early Mild Cognitive Impairment
Alwani Liyana Ahmad, Jose Sanchez-Bornot, Roberto C. Sotero, Damien Coyle, Zamzuri Idris, Ibrahima Faye
Alzheimer Disease poses a significant challenge, necessitating early detection for effective intervention. MRI is a key neuroimaging tool due to its ease of use and cost effectiveness. This study analyzes machine learning methods for MRI based biomarker selection and classification to distinguish between healthy controls and those who develop mild cognitive impairment within five years. Using 3 Tesla MRI data from ADNI and OASIS 3, we applied various machine learning techniques, including MATLAB Classification Learner app, nested cross validation, and Bayesian optimization. Data harmonization with polynomial regression improved performance. Consistent features identified were the entorhinal, hippocampus, lateral ventricle, and lateral orbitofrontal regions. For balanced ADNI data, Naive Bayes with z score harmonization performed best. For balanced OASIS 3, SVM with z score correction excelled. In imbalanced data, RUSBoost showed strong performance on ADNI and OASIS 3. Z score harmonization highlighted the potential of a semi automatic pipeline for early AD detection using MRI.
Read more8/12/2024
0
Augmented Risk Prediction for the Onset of Alzheimer's Disease from Electronic Health Records with Large Language Models
Jiankun Wang, Sumyeong Ahn, Taykhoom Dalal, Xiaodan Zhang, Weishen Pan, Qiannan Zhang, Bin Chen, Hiroko H. Dodge, Fei Wang, Jiayu Zhou
Alzheimer's disease (AD) is the fifth-leading cause of death among Americans aged 65 and older. Screening and early detection of AD and related dementias (ADRD) are critical for timely intervention and for identifying clinical trial participants. The widespread adoption of electronic health records (EHRs) offers an important resource for developing ADRD screening tools such as machine learning based predictive models. Recent advancements in large language models (LLMs) demonstrate their unprecedented capability of encoding knowledge and performing reasoning, which offers them strong potential for enhancing risk prediction. This paper proposes a novel pipeline that augments risk prediction by leveraging the few-shot inference power of LLMs to make predictions on cases where traditional supervised learning methods (SLs) may not excel. Specifically, we develop a collaborative pipeline that combines SLs and LLMs via a confidence-driven decision-making mechanism, leveraging the strengths of SLs in clear-cut cases and LLMs in more complex scenarios. We evaluate this pipeline using a real-world EHR data warehouse from Oregon Health & Science University (OHSU) Hospital, encompassing EHRs from over 2.5 million patients and more than 20 million patient encounters. Our results show that our proposed approach effectively combines the power of SLs and LLMs, offering significant improvements in predictive performance. This advancement holds promise for revolutionizing ADRD screening and early detection practices, with potential implications for better strategies of patient management and thus improving healthcare.
Read more5/28/2024
🎯
0
Addressing the Gaps in Early Dementia Detection: A Path Towards Enhanced Diagnostic Models through Machine Learning
Juan A. Berrios Moya
The rapid global aging trend has led to an increase in dementia cases, including Alzheimer's disease, underscoring the urgent need for early and accurate diagnostic methods. Traditional diagnostic techniques, such as cognitive tests, neuroimaging, and biomarker analysis, face significant limitations in sensitivity, accessibility, and cost, particularly in the early stages. This study explores the potential of machine learning (ML) as a transformative approach to enhance early dementia detection by leveraging ML models to analyze and integrate complex multimodal datasets, including cognitive assessments, neuroimaging, and genetic information. A comprehensive review of existing literature was conducted to evaluate various ML models, including supervised learning, deep learning, and advanced techniques such as ensemble learning and transformer models, assessing their accuracy, interpretability, and potential for clinical integration. The findings indicate that while ML models show significant promise in improving diagnostic precision and enabling earlier interventions, challenges remain in their generalizability, interpretability, and ethical deployment. This research concludes by outlining future directions aimed at enhancing the clinical utility of ML models in dementia detection, emphasizing interdisciplinary collaboration and ethically sound frameworks to improve early detection and intervention strategies for Alzheimer's disease and other forms of dementia.
Read more9/6/2024